P497: The value of endoscopic healing index monitoring for guiding infliximab dosing in patients with Crohn’s diseaseECCO'21 VirtualYear: 2021
Authors: Kantasiripitak, W.(1);Mathôt, R.(2);Oldenburg, B.(3);Buisson, A.(4);Ferrante, M.(5,6);Laharie, D.(7);D’Haens, G.(8);Vermeire, S.(5,6);Dreesen, E.(1,9);
(1)KU Leuven, Department of Pharmaceutical and Pharmacological Sciences, Leuven, Belgium;(2)Amsterdam UMC, Hospital Pharmacy, Amsterdam, The Netherlands;(3)University Medical Centre, Department of Gastroenterology and Hepatology, Utrecht, The Netherlands;(4)Estaing University Hospital, Department of Gastroenterology, Clermont-Ferrand, France;(5)University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium;(6)KU Leuven, Department of Chronic Diseases Metabolism and Ageing, Leuven, Belgium;(7)Haut-Lévêque Hospital, Department of Hepato-gastroenterology and Digestive Oncology Bordeaux UMC, Bordeaux, France;(8)Amsterdam UMC, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands;(9)Uppsala University, Department of Pharmacy, Uppsala, Sweden
P498: Diagnosing and differentiating iron deficiency in inflammatory disorders: still an unsolved mystery?ECCO'21 VirtualYear: 2021
Authors: Aksan, A.(1,2);Aksan, S.(1,3);Farrag, K.(1);Schröder, O.(1,3);Stein, J.M.(1,3,4);
(1)Interdisciplinary Crohn Colitis Centre Rhein-Main, Clinical Research, Frankfurt am Main, Germany;(2)Justus-Liebig University Giessen, Institute of Nutritional Science, Giessen, Germany;(3)DGD Clinics Frankfurt-Sachsenhausen, Gastroenterology and Clinical Nutrition, Frankfurt am Main, Germany;(4)Goethe University Frankfurt, Institute of Pharmaceutical Chemistry, Frankfurt am Main, Germany
P500: Assessing physical activity, fatigue and quality of life in an outpatient cohort of IBD patientsECCO'21 VirtualYear: 2021
Authors: Janssen , L.M.(1,2);Hendrix, E.M.B.(1,2);Spooren , C.E.G.M.(1,2);Stassen , L.P.S.(2,3);Pierik , M.J.(1,2);Jonkers , D.M.A.E.(1,2);
(1)Department of Internal Medicine Division of Gastroenterology and Hepatology, Maastricht University Medical Centre+, Maastricht, The Netherlands;(2)School for Nutrition and Translational Research in Metabolism NUTRIM, Maastricht University, Maastricht, The Netherlands;(3)Department of Surgery, Maastricht University Medical Centre+, Maastricht, The Netherlands
P502: Dietary habits and nutritional status in children and adolescents with Inflammatory Bowel Disease: an italian multicenter case-control study (NUTRIBD study)ECCO'21 VirtualYear: 2021
Authors: Gatti, S.(1);Vallorani, M.(1);zoppi, E.(1);aloi, M.(2);bramuzzo, M.(3);felici, E.(4);panceri, R.(5);ciacchini, B.(6);catassi, G.(2);grazian, F.(3);catassi, C.(1);
(1)Polytechnic University of Marche, clinica pediatrica, Ancona, Italy;(2)Università la Sapienza di Roma-, Dipartimento di Pediatria- Unità di Gastroenterologia ed Epatologia Pediatrica-, Roma- Italy, Italy;(3)Ospedale delle mamme e dei bambini - IRCCS 'Burlo Garofolo'-, Gastroenterologia- Endoscopia digestiva e Nutrizione Clinica-, Trieste- Italy, Italy;(4)Ospedale Pediatrico- AO SS Antonio e Biagio e C. Arrigo-, Pediatria ed Unità di Emergenza Pediatrica-, Alessandria -Italy, Italy;(5)Università di Milano BIcocca- Fondazione MBBM c/o Ospedale San Gerardo -, Clinica Pediatrica -, Monza- Italy, Italy;(6)Università del Piemonte Orientale-, Divisione di Pediatria- Dipartimento di scienze della salute-, Novara – Italy, Italy; NUTRIBD
P504: Effectiveness and safety of ustekinumab maintenance therapy in 103 patients with real-world ulcerative colitis: A GETAID multicentre cohort studyECCO'21 VirtualYear: 2021
Authors: Fumery, M.(1);Filippi, J.(2);Abitbol, V.(3);Biron, A.(4);Laharie, D.(5);Serrero, M.(6);Altwegg, R.(7);Bouhnik, Y.(8);Peyrinbiroulet, L.(9);Gilletta, C.(10);Roblin, X.(11);Pineton de Chambrun, G.(12);Vuitton, L.(13);Bourrier, A.(14);Nancey, S.(15);Gornet, J.M.(16);Nahon, S.(17);Bouguen, G.(18);Viennot, S.(19);Pariente, B.(20);Amiot, A.(21);
(1)Amiens University Hospital, Gastroenterology, Amiens Cedex 1, France;(2)Nice University Hospital, Gastroenterology, NIce, France;(3)Cochin Hospital, Gastroenterology, Paris, France;(4)Reims University hospital, Gastroenterology, Reims, France;(5)Bordeaux university hospital, Gastroenterology, Bordeaux, France;(6)Marseille University Hospital, Gastroenterology, Marseille, France;(7)Montpellier University Hospital, Gastroenterology, Montpellier, France;(8)Beaujon Hospital, Gastroenterology, Clichy, France;(9)Nancy University hospital, Gastroenterology, Nancy, France;(10)Toulouse University Hospital, Gastroenterology, Toulouse, France;(11)St Etienne University Hospital, Gastroenterology, Saint-Etienne, France;(12)Montpellier, Gastroenterology, Montpellier, France;(13)Besancon, Gastroenterology, Besancon, France;(14)Saint-Antoine Hospital, Gastroenterology, Paris, France;(15)Lyon Sud Hospital, Gastroenterology, Lyon, France;(16)Saint Louis Hospital, Gastroenterology, Paris, France;(17)Montfermeil Hospital, Gastroenterology, Montfermeil, France;(18)Rennes University Hospital, Gastroenterology, Rennes, France;(19)Caen University Hospital, Caen University Hospital, Caen, France;(20)Lille University Hospital, Gastroenterology, Lille, France;(21)Creteil University Hospital, Gastroenterology, Creteil, France; GETAID
P505: Early therapeutic drug monitoring after induction therapy with infliximab: correlation with intestinal ultrasoundECCO'21 VirtualYear: 2021
Authors: Nascimento, C.(1);Morão, B.(1);Frias Gomes, C.(1);Cúrdia Gonçalves, T.(2);Castro, F.(2);Moreira, M.(2);Cotter, J.(2);Pereira, F.(3);Caldeira, A.(3);Sousa, R.(3);Coelho, R.(4);Macedo, G.(4);Macedo, C.(5);Ferreira, M.(5);Cravo, M.(1);Glória, L.(1);Torres, J.(1);Palmela, C.(1);
(1)Hospital Beatriz Ângelo, Gastrenterology, Loures, Portugal;(2)Hospital da Senhora da Oliveira, Gastrenterology, Guimarães, Portugal;(3)Unidade Local de Saúde de Castelo Branco- EPE- Hospital Amato Lusitano, Gastrenterology, Castelo Branco, Portugal;(4)Centro Hospitalar de São João, Gastrenterology, Porto, Portugal;(5)Centro Hospitalar e Universitário de Coimbra, Gastrenterology, Coimbra, Portugal
P506: The Impact of Anxiety in Patients With Inflammatory Bowel Diseases Treated With Biologics during COVID Lockdown. A Comparative Study between Hospitalized and non-hospitalized patientsECCO'21 VirtualYear: 2021
Authors: Bertani, L.(1,2);Barberio, B.(3);Zanzi, F.(1);Maniero, D.(3);Ceccarelli, L.(4);Marsilio, I.(3);Minciotti, M.(2);Coppini, F.(1);Lorenzon, G.(3);Mumolo, M.G.(4);Zingone, F.(3);Costa, F.(4);Savarino, E.V.(3);
(1)University of Pisa, Translational Research and New Technologies in Medicine and Surgery, Pisa, Italy;(2)Tuscany North West ASL, Massa Apuane Hospital, Massa, Italy;(3)University of Padua, Surgery- Oncology and Gastroenterology - DISCOG, Padua, Italy;(4)Pisa University Hospital, General Surgery and Gastroenterology, Pisa, Italy
P507: Vulvar Crohn’s disease: A challenging diagnosisECCO'21 VirtualYear: 2021
Authors: Sahar, N.(1);Dahmani, W.(1);Nour, E.(1);Aya, H.(1);Wafa, B.A.(1);Aida, B.S.(1);Ahlem, B.(1);Mehdi, K.(1);Hanene, J.(1);Ali, J.(1);
(1)university hospital of Sahloul, gastroenterology, Sousse, Tunisia
P508: Dose adjustment in patients with moderate to severe ulcerative colitis: results from year 3 of the UNIFI maintenance study long-term extensionECCO'21 VirtualYear: 2021
Authors: Rowbotham, D.S.(1);Scherl, E.J.(2);Sands, B.E.(3);Panaccione, R.(4);Peyrin-Biroulet, L.(5);Zhang, H.(6);Miao, Y.(6);Leong, R.W.(7);Afif, W.(8);Arasaradnam, R.P.(9);Danese, S.(10);Marano, C.(6);
(1)Auckland City Hospital, Gastroenterology, Auckland, New Zealand;(2)New York Presbyterian Weill Cornell Medical College, Roberts Center for Inflammatory Bowel Disease, New York, United States;(3)Mount Sinai School of Medicine, Henry D. Janowitz Division of Gastroenterology, New York, United States;(4)University of Calgary, Inflammatory Bowel Disease Unit, Calgary, Canada;(5)Nancy University Hospital- Université de Lorraine, Department of Gastroenterology, Nancy, France;(6)Janssen Research & Development- LLC, Immunology, Spring House, United States;(7)Concord Repatriation General Hospital, Inflammatory Bowel Disease Clinic, New South Wales, Australia;(8)McGill University Health Centre, Division of Gastroenterology, Montreal, Canada;(9)University Hospital Coventry and Warwickshire, Gastrointestinal Medicine, Coventry, United Kingdom;(10)Instituto Clinico Humanitas, Department of Gastroenterology, Milano, Italy; UNIFI
P509: Influence of concomitant immunosuppresives in retention rate in Crohn´s Disease patients under ustekinumab in the SUSTAIN StudyECCO'21 VirtualYear: 2021
Authors: Chaparro, M.(1);Bastón Rey, I.(2);Fernández-Salgado, E.(3);González García, J.(4);Ramos, L.(5);Diz-Lois Palomares, M.T.(6);Argüelles, F.(7);Iglesias Flores, E.(8);Cabello, M.(9);Rubio Iturria, S.(10);Núñez Ortiz, A.(11);Charro, M.(12);Ginard, D.(13);Dueñas Sadornil, C.(14);Merino Ochoa, O.(15);Busquets, D.(16);Iyo, E.(17);Gutiérrez Casbas, A.(18);Ramírez de la Piscina, P.(19);Boscá-Watts, M.M.(20);Arroyo, M.(21);García, M.J.(22);Hinojosa, E.(23);Gordillo, J.(24);Martínez Montiel, P.(25);Velayos Jiménez, B.(26);Quílez Ivorra, C.(27);Vázquez Morón, J.M.(28);Huguet, J.M.(29);González Lama, Y.(30);Muñagorri Santos, A.I.(31);Amo, V.M.(32);Martín Arranz, M.D.(33);Bermejo, F.(34);Martínez Cadilla, J.(35);Fradejas Salazar, P.(36);Novella, C.(37);Vispo, E.(37);Barreiro-de Acosta, M.(2);Gisbert, J.P.(1);
(1)Hospital Universitario de La Princesa- Instituto de Investigación Sanitaria Princesa IIS-IP- Universidad Autónoma de Madrid and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBERehd, Gastroenterology Department, Madrid, Spain;(2)Complejo Hospitalario Universitario de Santiago, Gastroenterology Department, Santiago de Compostela, Spain;(3)Complejo Hospitalario de Pontevedra, Gastroenterology Department, Pontevedra, Spain;(4)Hospital Público Comarcal la Inmaculada, Gastroenterology Department, Almería, Spain;(5)Hospital Universitario de Canarias, Gastroenterology Department, Tenerife, Spain;(6)Hospital Universitario A Coruña, Gastroenterology Department, A Coruña, Spain;(7)Hospital Universitario Virgen Macarena and Universidad de Sevilla, Gastroenterology, Sevilla, Spain;(8)Hospital Universitario Reina Sofía, Gastroenterology Department, Córdoba, Spain;(9)Hospital Universitario Virgen de Valme, Gastroenterology Department, Sevilla, Spain;(10)Complejo Hospitalario de Navarra, Gastroenterology Department, Pamplona, Spain;(11)Hospital Universitario Virgen del Rocío, Gastroenterology Department, Sevilla, Spain;(12)Hospital de Barbastro, Gastroenterology Department, Barbastro, Spain;(13)Hospital Universitario Son Espases, Gastroenterology Department, Palma de Mallorca, Spain;(14)Hospital San Pedro de Alcántara, Gastroenterology Department, Cáceres, Spain;(15)Hospital Universitario Cruces, Gastroenterology Department, Barakaldo, Spain;(16)Hospital Universitari de Girona Doctor Josep Trueta, Gastroenterology Department, Girona, Spain;(17)Hospital Comarcal de Inca, Gastroenterology Department, Inca, Spain;(18)Hospital General Universitario de Alicante- Instituto de Investigación Sanitaria y Biomédica de Alicante ISABIAL- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas Digestivas CIBERehd- Madrid, Gastroenterology Department, Alicante, Spain;(19)Hospital Universitario de Araba-Txagorritxu, Gastroenterology Department, Araba-Txagorritxu, Spain;(20)Hospital Clínico de Valencia, Gastroenterology Department, Valencia, Spain;(21)Hospital Clínico Universitario Lozano Blesa, Gastroenterology Department, Zaragoza, Spain;(22)Hospital Universitario Marqués de Valdecilla- IDIVAL, Gastroenterology, Santander, Spain;(23)Hospital de Manises, Gastroenterology Department, Manises, Spain;(24)Hospital de la Santa Creu i Sant Pau, Gastroenterology Department, Barcelona, Spain;(25)Hospital Universitario 12 de Octubre, Gastroenterology Department, Madrid, Spain;(26)Hospital Universitario de Valladolidd, Gastroenterology Department, Valladolid, Spain;(27)Hospital Marina Baixa, Gastroenterology Department, Villajoyosa, Spain;(28)Hospital Universitario Juan Ramón Jiménez, Gastroenterology Department, Huelva, Spain;(29)Hospital General Universitario de Valencia, Gastroenterology Deparment, Valencia, Spain;(30)Hospital Universitario Puerta de Hierro, Gastroenterology Department, Majadahonda, Spain;(31)Hospital Universitario de Donostia, Gastroenterology Department, San Sebastián, Spain;(32)Hospital Regional de Málaga, Gastroenterology Department, Málaga, Spain;(33)Hospital Universitario de La Paz- Instituto de Investigación Sanitaria del Hospital La Paz IdiPaz- Facultad de Medicina- Universidad Autónoma de Madrid, Gastroenterology Department, Madrid, Spain;(34)Hospital Universitario de Fuenlabrada- Instituto de Investigación Sanitaria del Hospital La Paz IdiPaz, Gastroenterology Department, Madrid, Spain;(35)Hospital Álvaro Cunqueiro, Gastroenterology Department, Vigo, Spain;(36)Hospital Virgen de la Concha, Gastroenterology Department, Zamora, Spain;(37)Janssen Medical Department, Gastroenterology Department, Madrid, Spain
P511: Disease-specific risk factors for malnutrition development in IBDECCO'21 VirtualYear: 2021
Authors: Einav, L.(1);Hirsch, A.(1,2);Ron, Y.(1,2);Aviv Cohen, N.(1,2);Anbar, R.(1,3);Lahav, S.(2);Maharshak, N.(1,2);Fliss Isakov, N.(1,2);
(1)Tel Aviv University, Sackler Faculty of Medicine, Tel Aviv, Israel;(2)Tel Aviv Sourasky Medical Center, IBD Center- Department of Gastroenterology and Liver Diseases, Tel Aviv, Israel;(3)Tel Aviv Sourasky Medical Center, Nutrition and dietetics department, Tel Aviv, Israel
P512: Safety of reduced clinical monitoring in patients with stable Inflammatory Bowel Disease on maintenance thiopurine therapyECCO'21 VirtualYear: 2021
Authors: Jansen, F.M.(1);Smits, L.S.(1);Thomas, P.W.A.(1);den Broeder, N.(1);de Jong, D.J.(1);van Dop, W.A.(1);Hoentjen, F.(1);
(1)Radboud University Medical Centre, Gastroenterology and Hepatology, Nijmegen, The Netherlands
P513: Assessment of quality indicators in The Swedish Inflammatory Bowel Disease Registry (SWIBREG) for Crohn’s Disease treated with biological therapiesECCO'21 VirtualYear: 2021
Authors: Xu, C.(1);Byman, V.(2);Hossain, J.(2);Storlåhls, A.(2);Hedin, C.(2);
(1)Karolinska Universtiy Hospital, Division of Upper Abdominal Diseases, Stockholm, Sweden;(2)Karolinska Universtiy Hospital, Division of Gastroenterology- Medical Unit Gastroenterology- Dermatovenereology and Rheumatology, Stockholm, Sweden; Karolinska Gut Group
P514: Influence of the frequency of glucocorticosteroid therapy courses on the hormonal resistance in patients with ulcerative colitis.ECCO'21 VirtualYear: 2021
Authors: Knyazev, O.(1,2,3);Tishaeva, I.(2);Kagramanova, A.(1);Shkurko, T.(3);Veselov, A.(3);
(1)Moscow Clinical Scientific Center named after A.S. Loginov, Department of IBD, Moscow, Russian Federation;(2)State Scientific Centre of Coloproctology named after A.N. Ryzhyh, Department of IBD, Moscow, Russian Federation;(3)Research Institute of Health Organization and Medical Management, Organization of Coloproctology, Moscow, Russian Federation
P515: A 12-week tailored physical training program including dietary advice in children with Inflammatory Bowel Disease: a randomized crossover trialECCO'21 VirtualYear: 2021
Authors: Scheffers, L.(1);van den Berg, L.E.(1);Pijnenburg, M.W.(2);Utens, E.M.(3);Dieleman, G.C.(3);van der Ploeg , A.T.(4);Helbing, W.A.(5);Escher, J.C.(1);
(1)Erasmus MC - Sophia Children's Hospital, Paediatric Gastroenterology, Rotterdam, The Netherlands;(2)Erasmus MC - Sophia Children's hospital, Paediatric Respiratory Medicine, Rotterdam, The Netherlands;(3)Erasmus MC - Sophia Children's Hospital, Child and Adolescent Psychiatry/Psychology, Rotterdam, The Netherlands;(4)Erasmus MC - Sophia Children's Hospital, Center for Lysosomal and Metabolic Diseases, Rotterdam, The Netherlands;(5)Erasmus MC - Sophia Children's Hospital, Paediatric Cardiology, Rotterdam, The Netherlands Exercise study
P516: Serological biomarkers of tissue remodeling are associated with endoscopic remission in Crohn’s disease patients treated with GED-0301 (mongersen)ECCO'21 VirtualYear: 2021
Authors: Mortensen, J.(1);Feagan, B.(2);Bay-Jensen, A.C.(1);Karsdal, M.A.(1);Horan, G.(3);Harris, S.(4);Usikin, K.(3);
(1)Nordic Bioscience A/S, Biomarkers & Research, Herlev, Denmark;(2)Alimentiv, Clinical Trials, San Diego, United States;(3)Bristol-Myers Squibb, Translational Medicine, Princeton, United States;(4)Bristol-Myers Squibb, Translational Medicine, San Diego, United States